Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases

Periodontology 2000

Volumn 70, Issue 1, 2016, Pages 142-163

  Sorsa, Timo ^a   Gursoy, Ulvi K ^a   Nwhator, Solomon ^a   Hernandez, Marcela ^a   Tervahartiala, Taina ^a   Leppilahti, Jussi ^a   Gursoy, Mervi ^a   Könönen, Eija ^a   Emingil, Gulnur ^a   Pussinen, Pirkko J ^a   Mäntylä, Päivi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MATRIX METALLOPROTEINASE; MMP8 PROTEIN, HUMAN; NEUTROPHIL COLLAGENASE;

CHEMISTRY; ENZYMOLOGY; FEMALE; GINGIVITIS; HUMAN; MALE; METABOLISM; MOUTH DISEASE; PERIODONTAL DISEASES; PREGNANCY; PROCEDURES; SALIVA;

BIOMARKERS; DIAGNOSIS, ORAL; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASES; PERIODONTAL DISEASES; PREGNANCY; SALIVA;

EID: 84949647120     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/prd.12101     Document Type: Review

References (174)

1. Alfakry H, Sinisalo J, Paju S, Nieminen MS, Valtonen V, Tervahartiala T, Pussinen PJ, Sorsa T. The association of serum neutrophil markers and acute coronary syndrome. Scand J Immunol 2012: 76: 181-187.
2. Alfant B, Shaddox LM, Tobler J, Magnusson I, Aukhil I, Walker C. Matrix metalloproteinase levels in children with aggressive periodontitis. J Periodontol 2008: 79: 819-826.
3. Al-Tarawneh SK, Border MB, Dibble CF, Bencharit S. Defining salivary biomarkers using mass spectrometry-based proteomics: a systematic review. OMICS 2011: 15: 353-361.
4. Andelid K, Bake B, Rak S, Lindén A, Rosengren A, Ekberg-Jansson A. Myeloperoxidase as a marker of increasing systemic inflammation in smokers without severe airway symptoms. Respir Med 2007: 101: 888-895.
5. Behle JH, Sedaghatfar MH, Demmer RT, Wolf DL, Celenti R, Kebschull M, Belusko PB, Herrera-Abreu M, Lalla E, Papapanou PN. Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol 2009: 36: 287-294.
6. Berg M, Burrill DY, Fosdick LS. Chemical studies in periodontal disease; putrefaction of salivary proteins. J Dent Res 1946: 25: 231-246.
7. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K. The human tumor cell-derived collagenase stimulatory factor (renamed Ematrix metalloproteinaseRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995: 55: 434-439.
8. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, Meyer J, Cambien F, Tiret L. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003: 107: 1579-1585.
9. Borregaard N, Lollike K, Kjeldsen L, Sengeløv H, Bastholm L, Nielsen MH, Bainton DF. Human neutrophil granules and secretory vesicles. Eur J Haematol 1993: 51: 187-198.
10. Buduneli N, Kinane DF. Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. J Clin Periodontol 2011: 38: 85-105.
11. Butler GS, Overall CM. Matrix metalloproteinase processing of signaling molecules to regulate inflammation. Periodontol 2000 2013: 63: 123-148.
12. Caton JG, Ciancio SG, Blieden TM, Bradshaw M, Crout RJ, Hefti AF, Massaro JM, Polson AM, Thomas J, Walker C. Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: post-treatment effects. J Clin Periodontol 2001: 28: 782-789.
13. Caton JG, Ciancio SG, Blieden TM, Bradshaw M, Crout RJ, Hefti AF, Massaro JM, Polson AM, Thomas J, Walker C. Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planning in patients with adult periodontitis. J Periodontol 2000: 71: 521-532.
14. Chen D, Wang Q, Ma ZW, Chen FM, Chen Y, Xie GY, Wang QT, Wu ZF. Matrix metalloproteinase-2, matrix metalloproteinase-9 and TIMP-2 gene polymorphisms in Chinese patients with generalized aggressive periodontitis. J Clin Periodontol 2007: 34: 384-389.
15. Chen HY, Cox SW, Eley BM, Mantyla P, Ronka H, Sorsa T. Matrix metalloproteinase-8 levels and elastase activities in gingival crevicular fluid from chronic adult periodontitis patients. J Clin Periodontol 2000: 27: 366-369.
16. Chou YH, Ho YP, Lin YC, Hu KF, Yang YH, Ho KY, Wu YM, Hsi E, Tsai CC. MP-8 -799 C>T genetic polymorphism is associated with the susceptibility to chronic and aggressive periodontitis in Taiwanese. J Clin Periodontol 2011: 38: 1078-1084.
17. Ciancio S, Ashley R. Safety and efficacy of sub-antimicrobial-dose doxycycline therapy in patients with adult periodontitis. Adv Dent Res 1998: 12: 27-31.
18. Collin HL, Sorsa T, Meurman JH, Niskanen L, Salo T, Rönkä H, Konttinen YT, Koivisto AM, Uusitupa M. Salivary matrix metalloproteinase (matrix metalloproteinase-8) levels and gelatinase (matrix metalloproteinase-9) activities in patients with type 2 diabetes mellitus. J Periodontal Res 2000: 35: 259-265.
19. Crout RJ, Lee HM, Schroeder K, Crout H, Ramamurthy NS, Wiener M, Golub LM. The "Cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study. J Periodontol 1996: 67: 506-514.
20. Cuevas-Córdoba B, Santiago-García J. Saliva: a fluid of study for OMICS. OMICS 2014: 18: 87-97.
21. Culić O, Eraković V, Parnham MJ. Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 2001: 429: 209-229.
22. Dababneh R, Al-Wahadneh AM, Hamadneh S, Khouri A, Bissada NF. Periodontal manifestation of leukocyte adhesion deficiency type I. J Periodontol 2008: 79: 764-768.
23. de Souza AP, Trevilatto PC, Scarel-Caminaga RM, de Brito RB Jr, Barros SP, Line SR. Analysis of the matrix metalloproteinase-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis. J Clin Periodontol 2005: 32: 207-211.
24. Demirel K, Baer PN, McNamara TF. Topical application of doxycycline on periodontally involved root surfaces in vitro: comparative analysis of substantivity on cementum and dentin. J Periodontol 1991: 62: 312-316.
25. Ding Y, Liede K, Leppä S, Ingman T, Sepper R, Konttinen YT, Sorsa T. Gingival crevicular fluid and salivary matrix metalloproteinases of heavy smokers as indicators of periodontal health. Ann N Y Acad Sci 1994: 732: 453-455.
26. Divaris K, Monda KL, North KE, Olshan AF, Lange EM, Moss K, Barros SP, Beck JD, Offenbacher S. Genome-wide association study of periodontal pathogen colonization. J Dent Res 2012: 91: 21S-28S.
27. Ebersole JL, Schuster JL, Stevens J, Dawson D 3rd, Kryscio RJ, Lin Y, Thomas MV, Miller CS. Patterns of salivary analytes provide diagnostic capacity for distinguishing chronic adult periodontitis from health. J Clin Immunol 2013: 33: 271-279.
28. Ejeil AL, Igondjo-Tchen S, Ghomrasseni S, Pellat B, Godeau G, Gogly B. Expression of matrix metalloproteinases (matrix metalloproteinases) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva. J Periodontol 2003: 74: 188-195.
29. El-Maallem H, Fletcher J. Impaired neutrophil function and myeloperoxidase deficiency in pregnancy. Br J Haematol 1980: 44: 375-381.
30. El-Sharkawy H, Aboelsaad N, Eliwa M, Darweesh M, Alshahat M, Kantarci A, Hasturk H, Van Dyke TE. Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin. J Periodontol 2010: 81: 1635-1643.
31. Emingil G, Atilla G, Sorsa T, Luoto H, Kirilmaz L, Baylas H. The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis. J Periodontol 2004: 75: 106-115.
32. Emingil G, Han B, Ozdemir G, Tervahartiala T, Vural C, Atilla G, Baylas H, Sorsa T. Effect of azithromycin, as an adjunct to nonsurgical periodontal treatment, on microbiological parameters and gingival crevicular fluid biomarkers in generalized aggressive periodontitis. J Periodontal Res 2012: 47: 729-739.
33. Emingil G, Atilla G, Sorsa T, Tervahartiala T. The effect of adjunctive subantimicrobial dose doxycycline therapy on GCF Ematrix metalloproteinaseRIN levels in chronic periodontitis. J Periodontol 2008: 79: 469-476.
34. Emingil G, Han B, Gürkan A, Berdeli A, Tervahartiala T, Salo T, Pussinen PJ, Köse T, Atilla G, Sorsa T. Matrix metalloproteinase (matrix metalloproteinase)-8 and tissue inhibitors of metalloproteinases (TIMP)-1 gene polymorphisms in generalized aggressive periodontitis: GCF matrix metalloproteinase-8 and TIMP-1 levels and outcome of periodontal therapy. J Periodontol 2014: 85: 1070-1080.
35. Foulds G, Shepard RM, Johnson RB. The pharmokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990: 25: 73-82.
36. Gangbar S, Overall CM, McCulloch CA, Sodek J. Identification of polymorphonuclear leukocyte collagenase and gelatinase activities in mouthrinse samples: correlation with periodontal disease activity in adult and juvenile periodontitis. J Periodontal Res 1990: 25: 257-267.
37. Genco RJ, Borgnakke WS. Risk factors for periodontal disease. Periodontol 2000 2013: 62: 59-94.
38. Gesell-Salazar MG, Jehmlich N, Murr A, Dhople VM, Holtfreter B, Hammer E, Völker U, Kocher T. Identification of periodontitis associated changes in the proteome of whole human saliva by mass spectrometric analysis. J Clin Periodontol 2013: 40: 825-832.
39. Giannobile WV. Host-response therapeutics for periodontal diseases. J Periodontol 2008: 79: 1592-1600.
40. Golub LM, Ciancio S, Ramamurthy NS, Leung M, McNamara TF. Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodontal Res 1990: 25: 321-330.
41. Golub LM, Lee HM, Greenwald RA, Ryan ME, Sorsa T, Salo T, Giannobile WV. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res 1997: 46: 310-319.
42. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 1998: 12: 12-26.
43. Golub LM, Lee HM, Stoner JA, Sorsa T, Reinhardt RA, Wolff MS, Ryan ME, Nummikoski PV, Payne JB. Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women. J Periodontol 2008: 79: 1409-1418.
44. Golub LM, McNamara TF, D'Angelo G, Greenwald RA, Ramamurthy NS. A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dent Res 1987: 66: 1310-1314.
45. Golub LM, McNamara TF, Ryan ME, Kohut B, Blieden T, Payonk G, Sipos T, Baron HJ. Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 2001: 28: 146-156.
46. Golub LM, Ramamurthy NS, McNamara TF. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 1991: 2: 297-322.
47. Golub LM, Suomalainen K, Sorsa T. Host modulation with tetracyclines and their chemically modified analogues. Curr Opin Dent 1992: 2: 80-90.
48. Golub LM, Wolff M, Lee HM, McNamara TF, Ramamurthy NS, Zambon J, Ciancio S. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J Periodontal Res 1985: 20: 12-23.
49. Goncalves PF, Huang H, McAninley S, Alfant B, Harrison P, Aukhil I, Walker C, Shaddox LM. Periodontal treatment reduces matrix metalloproteinase levels in localized aggressive periodontitis. J Periodontol 2013: 84: 1801-1808.
50. Greene JC, Vermillion JR. Oral hygiene index: a method for classifying oral hygiene status. J Am Dent Soc 1960: 61: 172-179.
51. Guise TA. Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases. Genes Dev 2009: 23: 2117-2123.
52. Gurkan A, Emingil G, Saygan BH, Atilla G, Cinarcik S, Kose T, Berdeli A. Matrix metalloproteinase-2, -9, and -12 gene polymorphisms in generalized aggressive periodontitis. J Periodontol 2007: 78: 2338-2347.
53. Gurkan A, Emingil G, Saygan BH, Atilla G, Cinarcik S, Kose T, Berdeli A. Gene polymorphisms of matrix metalloproteinase-2, -9 and -12 in periodontal health and severe chronic periodontitis. Arch Oral Biol 2008: 53: 337-345.
54. Gürsoy M, Könönen E, Gürsoy UK, Tervahartiala T, Pajukanta R, Sorsa T. Periodontal status and neutrophilic enzyme levels in gingival crevicular fluid during pregnancy and postpartum. J Periodontol 2010: 81: 1790-1796.
55. Gürsoy M, Könönen E, Tervahartiala T, Gürsoy UK, Pajukanta R, Sorsa T. Longitudinal study of salivary proteinases during pregnancy and postpartum. J Periodontal Res 2010: 45: 496-503.
56. Gürsoy M, Pajukanta R, Sorsa T, Könönen E. Clinical changes in periodontium during pregnancy and post-partum. J Clin Periodontol 2008: 35: 576-583.
57. Gursoy UK, Könönen E, Huumonen S, Tervahartiala T, Pussinen PJ, Suominen AL, Sorsa T. Salivary type I collagen degradation end-products and related matrix metalloproteinases in periodontitis. J Clin Periodontol 2013: 40: 18-25.
58. Gursoy UK, Könönen E, Pradhan-Palikhe P, Tervahartiala T, Pussinen PJ, Suominen-Taipale L, Sorsa T. Salivary matrix metalloproteinase-8, TIMP-1, and ICTP as markers of advanced periodontitis. J Clin Periodontol 2010: 37: 487-493.
59. Gursoy UK, Könönen E, Pussinen PJ, Tervahartiala T, Hyvärinen K, Suominen AL, Uitto VJ, Paju S, Sorsa T. Use of host- and bacteria-derived salivary markers in detection of periodontitis: a cumulative approach. Dis Markers 2011: 30: 299-305.
60. Han B, Emingil G, Özdemir G, Tervahartiala T, Vural C, Atilla G, Baylas H, Sorsa T. Azithromycin as an adjunctive treatment of generalized severe chronic periodontitis: clinical, microbiologic, and biochemical parameters. J Periodontol 2012: 83: 1480-1491.
61. Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, van Hinsbergh VW, Helaakoski T, Kainulainen T, Rönkä H, Tschesche H, Salo T. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 1997: 272: 31504-31509.
62. Heikkinen AM, Sorsa T, Pitkäniemi J, Tervahartiala T, Kari K, Broms U, Koskenvuo M, Meurman JH. Smoking affects diagnostic salivary periodontal disease biomarker levels in adolescents. J Periodontol 2010: 81: 1299-1307.
63. Hernandez M, Martinez B, Tejerina JM, Valenzuela MA, Gamonal J. Matrix metalloproteinase-13 and TIMP-1 determinations in progressive chronic periodontitis. J Clin Periodontol 2007: 34: 729-735.
64. Hernandez M, Dutzan N, Garcia-Sesnich J, Abusleme L, Dezerega A, Silva N, Gonzalez FE, Vernal R, Sorsa T, Gamonal J. Host-pathogen interactions in progressive chronic periodontitis. J Dent Res 2011: 90: 1164-1170.
65. Hernandez M, Gamonal J, Tervahartiala T, Mantyla P, Rivera O, Dezerega A, Dutzan N, Sorsa T. Associations between matrix metalloproteinase-8 and -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: a longitudinal study. J Periodontol 2010: 81: 1644-1652.
66. Hernandez M, Valenzuela MA, Lopez-Otin C, Alvarez J, Lopez JM, Vernal R, Gamonal J. Matrix metalloproteinase-13 is highly expressed in destructive periodontal disease activity. J Periodontol 2006: 77: 1863-1870.
67. Hernandez Rios M, Sorsa T, Obregon F, Tervahartiala T, Valenzuela MA, Pozo P, Dutzan N, Lesaffre E, Molas M, Gamonal J. Proteolytic roles of matrix metalloproteinase (matrix metalloproteinase)-13 during progression of chronic periodontitis: initial evidence for matrix metalloproteinase-13/matrix metalloproteinase-9 activation cascade. J Clin Periodontol 2009: 36: 1011-1017.
68. Hernández M, Gamonal J, Salo T, Tervahartiala T, Hukkanen M, Tjäderhane L, Sorsa T. Reduced expression of lipopolysaccharide-induced CXC chemokine in Porphyromonas gingivalis-induced experimental periodontitis in matrix metalloproteinase-8 null mice. J Periodontal Res 2011: 46: 58-66.
69. Herr AE, Hatch AV, Giannobile WV, Throckmorton DJ, Tran HM, Brennan JS, Singh AK. Integrated microfluidic platform for oral diagnostics. Proc Natl Acad Sci U S A 2007: 1098: 362-374.
70. Herrera D, Matesanz P, Bascones-Martínez A, Sanz M. Local and systemic antimicrobial therapy in periodontics. J Evid Based Dent Pract 2012: 12: 50-60.
71. Hill PA, Murphy G, Docherty AJ, Hembry RM, Millican TA, Reynolds JJ, Meikle MC. The effects of selective inhibitors of matrix metalloproteinases (matrix metalloproteinases) on bone resorption and the identification of matrix metalloproteinases and TIMP-1 in isolated osteoclasts. J Cell Sci 1994: 107: 3055-3064.
72. Holla IL, Hrdlickova B, Vokurka J, Fassmann A. Matrix metalloproteinase 8 (matrix metalloproteinase-8) gene polymorphisms in chronic periodontitis. Arch Oral Biol 2012: 57: 188-196.
73. Holla LI, Fassmann A, Muzik J, Vanek J, Vasku A. Functional polymorphisms in the matrix metalloproteinase-9 gene in relation to severity of chronic periodontitis. J Periodontol 2006: 77: 1850-1855.
74. Ilgenli T, Vardar-Sengul S, Gurkan A, Sorsa T, Stackelberg S, Kose T, Atilla G. Gingival crevicular fluid matrix metalloproteinase-13 levels and molecular forms in various types of periodontal diseases. Oral Dis 2006: 12: 573-579.
75. Ingman T, Sorsa T, Suomalainen K, Halinen S, Lindy O, Lauhio A, Saari H, Konttinen YT, Golub LM. Tetracycline inhibition and the cellular source of collagenase in gingical crevicular fluid in different periodontal disease. A review article. J Periodontol 1993: 64: 82-88.
76. Ingman T, Tervahartiala T, Ding Y, Tschesche H, Haerian A, Kinane D, Konttinen YT, Sorsa T. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 1996: 23: 1127-1132.
77. Isaza-Guzmán DM, Arias-Osorio C, Martinez-Pabon MC, Tobon-Arroyave SI. Salivary levels of matrix metalloproteinase (matrix metalloproteinase)-9 and tissue inhibitor of matrix metalloproteinase (TIMP)-1: a pilot study about the relationship with periodontal status and matrix metalloproteinase-9 (-1562C/T) gene promoter polymorphism. Arch Oral Biol 2011: 56: 401-411.
78. Jones GT, Phillips VL, Harris EL, Rossaak JI, van Rij AM. Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm. J Vasc Surg 2003: 38: 1363-1367.
79. Kardesler L, Biyikoglu B, Cetinkalp S, Pitkala M, Sorsa T, Buduneli N. Crevicular fluid matrix metalloproteinase-8, -13, and TIMP-1 levels in type 2 diabetics. Oral Dis 2010: 16: 476-481.
80. Kaufman E, Lamster IB. The diagnostic applications of saliva - a review. Crit Rev Oral Biol Med 2002: 13: 197-212.
81. Keles GC, Gunes S, Sumer AP, Sumer M, Kara N, Bagci H, Koprulu H. Association of matrix metalloproteinase-9 promoter gene polymorphism with chronic periodontitis. J Periodontol 2006: 77: 1510-1514.
82. Kiili M, Cox SW, Chen HY, Wahlgren J, Maisi P, Eley BM, Salo T, Sorsa T. Collagenase-2 (matrix metalloproteinase-8) and collagenase-3 (matrix metalloproteinase-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J Clin Periodontol 2002: 29: 224-232.
83. Kinane DF, Mombelli A. Periodontal disease. Foreword. Front Oral Biol 2012: 15: v-ix.
84. Kinney JS, Morelli T, Oh M, Braun TM, Ramseier CA, Sugai JV, Giannobile WV. Crevicular fluid biomarkers and periodontal disease progression. J Clin Periodontol 2013: 41: 113-120.
85. Kivelä-Rajamäki M, Maisi P, Srinivas R, Tervahartiala T, Teronen O, Husa V, Salo T, Sorsa T. Levels and molecular forms of matrix metalloproteinase-7 (matrilysin-1) and matrix metalloproteinase-8 (collagenase-2) in diseased human peri-implant sulcular fluid (PISF). J Periodontal Res 2003: 38: 583-590.
86. Kivelä-Rajamäki M, Teronen O, Maisi P, Husa V, Tervahartiala T, Pirilä E, Salo T, Mellanen L, Sorsa T. Laminin-5 gamma-2 chain and collagenase-2 (matrix metalloproteinase-8) in human peri-impant sulcular fluid. Clin Oral Impl Res 2003: 14: 158-165.
87. Knauper V, Smith B, Lopez-Otin C, Murphy G. Activation of progelatinase B (promatrix metalloproteinase-9) by active collagenase-3 (matrix metalloproteinase-13). Eur J Biochem 1997: 248: 369-373.
88. Kornman KS. Host modulation as a therapeutic strategy in the treatment of periodontal disease. Clin Infect Dis 1999: 28: 520-526.
89. Krause PJ, Ingardia CJ, Pontius LT, Malech HL, LoBello TM, Maderazo EG. Host defense during pregnancy: neutrophil chemotaxis and adherence. Am J Obstet Gynecol 1987: 157: 274-280.
90. Kuula H, Salo T, Pirilä E, Tuomainen AM, Jauhiainen M, Uitto VJ, Tjäderhane L, Pussinen PJ, Sorsa T. Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis. Infect Immun 2009: 77: 850-859.
91. Lahdentausta L, Sorsa T, Pussinen PJ, Pesonen E. The effect of smoking on diagnostic value of serum matrix metalloproteinase-8 in acute coronary syndrome. J Mol Biomark Diagn 2013: S4: -002.
92. Leppilahti JM, Ahonen MM, Hernández M, Munjal S, Netuschil L, Uitto VJ, Sorsa T, Mäntylä P. Oral rinse matrix metalloproteinase-8 point-of-care immuno test identifies patients with strong periodontal inflammatory burden. Oral Dis 2011: 17: 115-122.
93. Leppilahti JM, Hernández-Ríos PA, Gamonal JA, Tervahartiala T, Brignardello-Petersen R, Mantyla P, Sorsa T, Hernández M. Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis. J Clin Periodontol 2014: 41: 348-356 doi: 10.1111/jcpe.12223.
94. Leppilahti JM, Kallio MA, Tervahartiala T, Sorsa T, Mäntylä P. Gingival crevicular fluid matrix metalloproteinase-8 levels predict treatment outcome among smokers with chronic periodontitis. J Periodontol 2014: 85: 250-260.
95. Li G, Yue Y, Tian Y, Li JL, Wang M, Liang H, Liao P, Loo WT, Cheung MN, Chow LW. Association of matrix metalloproteinase (matrix metalloproteinase)-1, 3, 9, interleukin-2, 8 and cyclooxygenase (COX)-2 gene polymorphisms with chronic periodontitis in a Chinese population. Cytokine 2012: 60: 552-560.
96. Liede KE, Haukka JK, Hietanen JH, Mattila MH, Rönkä H, Sorsa T. The association between smoking cessation and periodontal status and salivary proteinase levels. J Periodontol 1999: 70: 1361-1368.
97. Liljestrand JM, Gursoy UK, Hyvärinen K, Sorsa T, Suominen AL, Könönen E, Pussinen PJ. Combining salivary pathogen and serum antibody levels improves their diagnostic ability in detection of periodontitis. J Periodontol 2014: 85: 123-131.
98. Liu KZ, Hynes A, Man A, Alsagheer A, Singer DL, Scott DA. Increased local matrix metalloproteinase-8 expression in the periodontal connective tissues of smokers with periodontal disease. Biochim Biophys Acta 2006: 1762: 775-780.
99. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, Taubert KA, Newburger JW, Gornik HL, Gewitz MH, Wilson WR, Smith SC Jr, Baddour LM. American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, and Council on Clinical Cardiology. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent 44 association?: a scientific statement from the American Heart Association. Circulation 2012: 125: 2520-2544.
100. Loo WT, Wang M, Jin LJ, Cheung MN, Li GR. Association of matrix metalloproteinase (matrix metalloproteinase-1, matrix metalloproteinase-3 and matrix metalloproteinase-9) and cyclooxygenase-2 gene polymorphisms and their proteins with chronic periodontitis. Arch Oral Biol 2011: 56: 1081-1090.
101. Mäkelä M, Salo T, Uitto VJ, Larjava H. Matrix metalloproteinases (matrix metalloproteinase-2 and matrix metalloproteinase-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res 1994: 73: 1397-1406.
102. Mäntylä P, Stenman M, Kinane DF, Tikanoja S, Luoto H, Salo T, Sorsa T. Gingival crevicular fluid collagenase-2 (matrix metalloproteinase-8) test stick for chair-side monitoring of periodontitis. J Periodontal Res 2003: 38: 436-439.
103. Marcaccini AM, Meschiari CA, Zuardi LR, de Sousa TS, Taba M Jr, Teofilo JM, Jacob-Ferreira AL, Tanus-Santos JE, Novaes AB Jr, Gerlach RF. Gingival crevicular fluid levels of matrix metalloproteinase-8, matrix metalloproteinase-9, TIMP-2, and MPO decrease after periodontal therapy. J Clin Periodontol 2010: 37: 180-190.
104. Marcaccini AM, Amato PA, Leão FV, Gerlach RF, Ferreira JT. Myeloperoxidase activity is increased in gingival crevicular fluid and whole saliva after fixed orthodontic appliance activation. Am J Orthod Dentofacial Orthop 2010: 138: 613-616.
105. Marcaccini AM, Novaes AB Jr, Meschiari CA, Souza SL, Palioto DB, Sorgi CA, Faccioli LH, Tanus-Santos JE, Gerlach RF. Circulating matrix metalloproteinase-8 (matrix metalloproteinase-8) and matrix metalloproteinase-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy. Clin Chim Acta 2009: 409: 117-122.
106. Medley TL, Cole TJ, Dart AM, Gatzka CD, Kingwell BA. Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol 2004: 24: 1479-1484.
107. Menon R, McIntyre JO, Matrisian LM, Fortunato SJ. Salivary proteinase activity: a potential biomarker for preterm premature rupture of the membranes. Am J Obstet Gynecol 2006: 194: 1609-1615.
108. Meschiari CA, Marcaccini AM, Santos Moura BC, Zuardi LR, Tanus-Santos JE, Gerlach RF. Salivary matrix metalloproteinases, TIMPs, and MPO levels in periodontal disease patients and controls. Clin Chim Acta 2013: 421: 140-146.
109. Michalowicz BS, Pihlstrom BL, Drisko CL, Cobb CM, Killoy WJ, Caton JG, Lowenguth RA, Quinones C, Encarnacion M, Knowles M. Evaluation of periodontal treatments using controlled-release tetracycline fibers: maintenance response. J Periodontol 1995: 66: 708-715.
110. Miller CS, Foley JD, Bailey AL, Campell CL, Humphries RL, Christodoulides N, Floriano PN, Simmons G, Bhagwandin B, Jacobson JW, Redding SW, Ebersole JL, McDevitt JT. Current developments in salivary diagnostics. Biomark Med 2010: 4: 171-189.
111. Miller CS, King CP Jr, Langub MC, Kryscio RJ, Thomas MV. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc 2006: 137: 322-329.
112. Mirrielees J, Crofford LJ, Lin Y, Kryscio RJ, Dawson DR 3rd, Ebersole JL, Miller CS. Rheumatoid arthritis and salivary biomarkers of periodontal disease. J Clin Periodontol 2010: 37: 1068-1074.
113. Mizon-Gerard F, de Groote P, Lamblin N, Hermant X, Dallongeville J, Amouyel P, Bauters C, Helbecque N. Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction. Eur Heart J 2004: 25: 688-693.
114. Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010: 63: 425-433.
115. Morozumi T, Kubota T, Sugita N, Itagaki M, Yoshie H. Alterations of gene expression in human neutrophils induced by smoking cessation. J Clin Periodontol 2004: 31: 1110-1116.
116. Nannuru KC, Futakuchi M, Varney ML, Vincent TM, Marcusson EG, Singh RK. Matrix metalloproteinase (matrix metalloproteinase)-13 regulates mammary tumor-induced osteolysis by activating matrix metalloproteinase9 and transforming growth factor-beta signaling at the tumor-bone interface. Cancer Res 2010: 70: 3494-3504.
117. Navazesh M, Kumar SK. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 2008: 139 (Suppl.): 35S-40S.
118. Nordskog BK, Blixt AD, Morgan WT, Fields WR, Hellmann GM. Matrix-degrading and pro-inflammatory changes in human vascular endothelial cells exposed to cigarette smoke condensate. Cardiovasc Toxicol 2003: 3: 101-117.
119. Novak MJ, Johns LP, Miller RC, Bradshaw MH. Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis. J Periodontol 2002: 73: 762-769.
120. Nwhator SO, Ayanbadejo PO, Umeizudike KA, Opeodu OI, Agbelusi GA, Olamijulo JA, Arowojolu MO, Sorsa T, Babajide BS, Opedun DO. Clinical correlates of a lateral-flow immunoassay oral risk indicator. J Periodontol 2014: 85: 188-194.
121. Nwhator SO, Opeodu OI, Ayanbadejo PO, Umeizudike KA, Olamijulo JA, Alade GO, Agbelusi GA, Arowojolu M, Sorsa T. Could periodontitis affect time to conception? Ann Med Health Sci Res 2014: 4: 817-822.
122. Nwhator SO, Umeizudike KA, Ayanbadejo PO, Agbelusi GA, Arowojolu M, Sorsa T, Opeodu OI, Olamijulo JA, Akaba GO, Ekele BA. Black women's predisposition to preterm birth; could we be near the answer? Int J Tropic Dis Health 2014: 4: 194-203.
123. Nwhator SO, Umeizudike KA, Ayanbadejo PO, Opeodu OI, Olamijulo JA, Sorsa T. Another reason for impeccable oral hygiene oral hygiene-sperm count link. J Contemp Dent Pract 2014: 15: 352-358.
124. Ozçaka O, Biçakci N, Pussinen P, Sorsa T, Köse T, Buduneli N. Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis. Oral Dis 2011: 1: 68-76.
125. Palm F, Lahdentausta L, Sorsa T, Tervahartiala T, Gokel P, Buggle F, Safer A, Becher H, Grau AJ, Pussinen P. Biomarkers of periodontitis and inflammation in ischemic stroke: a case-control study. Innate Immun 2013: 20: 511-518.
126. Persson L, Bergström J, Gustafsson A. Effect of tobacco smoking on neutrophil activity following periodontal surgery. J Periodontol 2003: 74: 1475-1482.
127. Pirhan D, Atilla G, Emingil G, Tervahartiala T, Sorsa T, Berdeli A. Matrix metalloproteinase-13 promoter polymorphisms in patients with chronic periodontitis: effects on GCF matrix metalloproteinase-13 levels and outcome of periodontal therapy. J Clin Periodontol 2009: 36: 474-481.
128. Pirilä E, Ramamurthy N, Maisi P, McClain S, Kucine A, Wahlgren J, Golub L, Salo T, Sorsa T. Wound healing in ovariectomized rats: effects of chemically modified tetracycline (CMT-8) and estragen on matrix metalloproteinases-8, -13 and type I collagen expression. Curr Med Chem 2001: 8: 281-294.
129. Pivetta E, Scapolan M, Pecolo M, Wassermann B, Abu-Rumeileh I, Balestreri L, Borsatti E, Tripodo C, Colombatti A, Spessotto P. Matrix metalloproteinase-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases. Breast Cancer Res 2011: 13: R105.
130. Pollanen PJ, Karhunen PJ, Mikkelsson J, Laippala P, Perola M, Penttila A, Mattila KM, Koivula T, Lehtimaki T. Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study. Arterioscler Thromb Vasc Biol 2001: 21: 1446-1450.
131. Pozo P, Valenzuela MA, Melej C, Zaldivar M, Puente J, Martinez B, Gamonal J. Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients. J Periodontal Res 2005: 40: 199-207.
132. Pussinen PJ, Sarna S, Puolakkainen M, Ohlin H, Sorsa T, Pesonen E. The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence. Int J Cardiol 2013: 167: 362-368.
133. Rai B, Kharb S, Jain R, Anand SC. Biomarkers of periodontitis in oral fluids. J Oral Sci 2008: 50: 53-56.
134. Raitio A, Tuomas H, Kokkonen N, Salo T, Sorsa T, Hanemaaijer R, Oikarinen A. Levels of matrix metalloproteinase-2, -9 and -8 in the skin, serum and saliva of smokers and non-smokers. Arch Dermatol Res 2005: 297: 242-248.
135. Ramseier CA, Kinney JS, Herr AE, Braun T, Sugai JV, Shelburne CA, Rayburn LA, Tran HM, Singh AK, Giannobile WV. Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol 2009: 80: 436-446.
136. Rathnayake N, Akerman S, Klinge B, Lundegren N, Jansson H, Tryselius Y, Sorsa T, Gustafsson A. Salivary biomarkers of oral health: a cross-sectional study. J Clin Periodontol 2013: 40: 140-147.
137. Roderfeld M, Graf J, Giese B, Salguero-Palacios R, Tschuschner A, Müller-Newen G, Roeb E. Latent matrix metalloproteinase-9 is bound to TIMP-1 before secretion. Biol Chem 2007: 388: 1227-1234.
138. Rydziel S, Durant D, Canalis E. Platelet-derived growth factor induces collagenase 3 transcription in osteoblasts through the activator protein 1 complex. J Cell Physiol 2000: 184: 326-333.
139. Salminen A, Gursoy UK, Paju S, Hyvärinen K, Mäntylä P, Buhlin K, Könönen E, Nieminen MS, Sorsa T, Sinisalo J. Salivary biomarkers of bacterial burden, inflammatory response, and tissue destruction in periodontitis. J Clin Periodontol 2014: 41: 442-450.
140. Schaefer AS, Richter GM, Nothnagel M, Laine ML, Noack B, Glas J, Schrezenmeir J, Groessner-Schreiber B, Jepsen S, Loos BG, Schreiber S. COX-2 is associated with periodontitis in Europeans. J Dent Res 2010: 89: 384-388.
141. Sexton WM, Lin Y, Kryscio RJ, Dawson DR 3rd, Ebersole JL, Miller CS. Salivary biomarkers of periodontal disease in response to treatment. J Clin Periodontol 2011: 38: 434-441.
142. Silva N, Dutzan N, Hernandez M, Dezerega A, Rivera O, Aguillon JC, Aravena O, Lastres P, Pozo P, Vernal R, Gamonal J. Characterization of progressive periodontal lesions in chronic periodontitis patients: levels of chemokines, cytokines, matrix metalloproteinase-13, periodontal pathogens and inflammatory cells. J Clin Periodontol 2008: 35: 206-214.
143. Smith PC, Munoz VC, Collados L, Oyarzun AD. In situ detection of matrix metalloproteinase-9 (matrix metalloproteinase-9) in gingival epithelium in human periodontal disease. J Periodontal Res 2004: 39: 87-92.
144. Sørensen LT, Nielsen HB, Kharazmi A, Gottrup F. Effect of smoking and abstention on oxidative burst and reactivity of neutrophils and monocytes. Surgery 2004: 136: 1047-1053.
145. Sorsa T, Ingman T, Suomalainen K, Haapasalo M, Konttinen YT, Lindy O, Saari H, Uitto VJ. Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases. Infect Immun 1992: 60: 4491-4495.
146. Sorsa T, Mantyla P, Tervahartiala T, Pussinen PJ, Gamonal J, Hernandez M. Matrix metalloproteinase activation in diagnostics of periodontitis and systemic inflammation. J Clin Periodontol 2011: 38: 817-819.
147. Sorsa T, Tervahartiala T, Leppilahti J, Hernandez M, Gamonal J, Tuomainen AM, Lauhio A, Pussinen PJ, Mäntylä P. Collagenase-2 (matrix metalloproteinase-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines. Pharmacol Res 2011: 63: 108-113.
148. Sorsa T, Mäntylä P, Rönkä H, Kallio P, Kallis GB, Lundqvist C, Kinane DF, Salo T, Golub LM, Teronen O, Tikanoja S. Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Ann N Y Acad Sci 1999: 30: 130-140.
149. Sorsa T, Tjäderhane L, Salo T. Matrix metalloproteinases (matrix metalloproteinases) in oral diseases. Oral Dis 2004: 10: 311-318.
150. Sorsa T, Hernández M, Leppilahti J, Munjal S, Netuschil L, Mäntylä P. Detection of gingival crevicular fluid matrix metalloproteinase-8 levels with different laboratory and chair-side methods. Oral Dis 2010: 16: 39-45.
151. Sorsa T, Tjaderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, Golub LM, Brown DL, Mäntylä P. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006: 38: 306-321.
152. Sorsa T, Uitto VJ, Suomalainen K, Vauhkonen M, Lindy S. Comparison of interstitial collagenases from human gingiva, sulcular fluid and polymorphonuclear leukocytes. J Periodontal Res 1988: 23: 386-393.
153. Söder B, Airila Mansson S, Soder PO, Kari K, Meurman J. Levels of matrix metalloproteinases-8 and -9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase-9 and cholesterol in blood. J Periodontal Res 2006: 41: 411-417.
154. Söder PO, Meurman JH, Jogestrand T, Nowak J, Söder B. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis. J Periodontal Res 2009: 44: 452-458.
155. Taylor JJ, Preshaw PM, Lalla E. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Periodontol 2013: 84 (4 Suppl.): S113-S134.
156. Teronen O, Konttinen YT, Lindqvist C, Salo T, Ingman T, Lauhio A, Ding Y, Santavirta S, Sorsa T. Human neutrophil collagenase matrix metalloproteinase-8 in peri-implant sulcus fluid and its inhibition by clodronate. J Dent Res 1997: 76: 1529-1537.
157. Tervahartiala T, Pirila E, Ceponis A, Maisi P, Salo T, Tuter G, Kallio P, Tornwall J, Srinivas R, Konttinen YT, Sorsa T. The in vivo expression of the collagenolytic matrix metalloproteinases (matrix metalloproteinase-2, -8, -13, and -14) and matrilysin (matrix metalloproteinase-7) in adult and localized juvenile periodontitis. J Dent Res 2000: 79: 1969-1977.
158. Teumer A, Holtfreter B, Völker U, Petersmann A, Nauck M, Biffar R, Völzke H, Kroemer HK, Meisel P, Homuth G, Kocher T. Genome-wide association study of chronic periodontitis in a general German population. J Clin Periodontol 2013: 40: 977-985.
159. Tuomainen AM, Kormi I, Havulinna AS, Tervahartiala T, Salomaa V, Sorsa T, Pussinen PJ. Serum tissue-degrading proteinases and incident cardiovascular disease events. Eur J Prev Cardiol 2014: 21: 806-812.
160. Tuomainen AM, Nyyssönen K, Laukkanen JA, Tervahartiala T, Tuomainen TP, Salonen JT, Sorsa T, Pussinen PJ. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler Thromb Vasc Biol 2007: 27: 2722-2728.
161. Tuter G, Serdar M, Kurtis B, Walker SG, Atak A, Toyman U, Pinar S, Aykan T. Effects of scaling and root planing and subantimicrobial dose doxycycline on gingival crevicular fluid levels of matrix metalloproteinase-8, -13 and serum levels of HsCRP in patients with chronic periodontitis. J Periodontol 2010: 81: 1132-1139.
162. Uitto VJ, Airola K, Vaalamo M, Johansson N, Putnins EE, Firth JD, Salonen J, Lopez-Otin C, Saarialho-Kere U, Kahari VM. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol 1998: 152: 1489-1499.
163. Uitto VJ, Suomalainen K, Sorsa T. Salivary collagenase. Origin, characteristics and relationship to periodontal health. J Periodontal Res 1990: 25: 135-142.
164. Uitto VJ, Tryggvason K, Sorsa T. Collagenolytic enzymes in periodontal diseases. Proc Finn Dent Soc 1987: 83: 119-130.
165. Westerlund U, Ingman T, Lukinmaa PL, Salo T, Kjeldsen L, Borregaard N, Tjäderhane L, Konttinen YT, Sorsa T. Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis. J Dent Res 1996: 75: 1553-1563.
166. Wick PA, Mombelli A, Pagano S, Moren X, Giannopoulou C, Mach F, Roux-Lombard P, Vuilleumier N. Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis. J Periodontal Res 2013: 48: 350-356.
167. Witkin SS, Linhares IM, Bongiovanni AM, Herway C, Skupski D. Unique alterations in infection-induced immune activation during pregnancy. BJOG 2011: 118: 145-153.
168. Yakob M, Meurman JH, Sorsa T, Soder B. Treponema denticola associates with increased levels of matrix metalloproteinase-8 and matrix metalloproteinase-9 in gingival crevicular fluid. Oral Dis 2013: 19: 694-701.
169. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 2007: 131: 1557-1566.
170. Ye S, Patodi N, Walker-Bone K, Reading I, Cooper C, Dennison E. Variation in the matrix metalloproteinase-3, -7, -12 and -13 genes is associated with functional status in rheumatoid arthritis. Int J Immunogenet 2007: 34: 81-85.
171. Ye S. Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 2000: 19: 623-629.
172. Yoon S, Kuivaniemi H, Gatalica Z, Olson JM, Buttice G, Ye S, Norris BA, Malcom GT, Strong JP, Tromp G. Matrix metalloproteinase13 promoter polymorphism is associated with atherosclerosis in the abdominal aorta of young black males. Matrix Biol 2002: 21: 487-498.
173. Zappacosta B, Martorana GE, Papini S, Gervasoni J, Iavarone F, Fasanella S, Giardina B, De Sole P, Persichilli S. Morpho-functional modifications of human neutrophils induced by aqueous cigarette smoke extract: comparison with chemiluminescence activity. Luminescence 2011: 26: 331-335.
174. Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999: 99: 1788-1794.